Trial intelligence / Profile preview

Fybex fibrin sealant in total knee arthroplasty

2005-001229-27Phase 3Completed

Sponsor
Bio Products Laboratory
Start
Sep 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of Fybex in postoperative hemorrhage (2 arms), sponsored by Bio Products Laboratory. Primary endpoint: Postoperative blood loss. Started Sep 2005; status: completed.

02

Drugs

Fybex
03

Conditions

postoperative hemorrhage

Beyond the preview

Go deeper on 2005-001229-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001229-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call